NEW YORK (GenomeWeb News) - Sigma-Aldrich said today that it has signed an agreement to provide its RNAi technologies to the University of Montreal’s Institute of Research in Immunology and Cancer.
Under the agreement, the institute's high-throughput screening facility will have access to Sigma-Aldrich’s Mission RNAi IP portfolio and its shRNA library collection for human and mouse genomes.
Funding for the research was provided by Genome Quebec and by Sigma-Aldrich.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.